Related Experiment Video
Updated: May 14, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Effect of percutaneous ventricular assist devices on renal function
Huijuan Mao1, Anna Giuliani, Lourdes Blanca-Martos
1Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy.
Blood Purification
|January 25, 2013
Summary
Percutaneous ventricular assist devices (VADs) offer rapid hemodynamic support for critical events. This review examines their mechanical principles and clinical data, focusing on potential renal effects in cardiac patients.
Area of Science:
- Cardiology
- Biomedical Engineering
- Nephrology
Background:
- Hemodynamic instability refractory to pharmacologic therapies necessitates advanced circulatory support.
- Ventricular assist devices (VADs) improve systemic circulation and reduce ventricular workload.
- Percutaneous VADs are crucial for acute critical events due to rapid deployment.
Purpose of the Study:
- To review the mechanical principles of percutaneous VADs.
- To analyze clinical studies on percutaneous VADs.
- To investigate the potential renal effects of percutaneous VADs.
Main Methods:
- Literature review of mechanical principles.
- Analysis of clinical studies focusing on percutaneous VADs.
- Exclusion of extracorporeal membrane oxygenation systems.
Main Results:
- Percutaneous VADs provide rapid circulatory support.
- Implantable VADs serve as bridge therapy for end-stage heart failure.
- The review focuses on cardiac support devices, excluding ECMO.
Conclusions:
- Percutaneous VADs are vital for acute hemodynamic support.
- Understanding their renal effects is critical for patient management.
- Further research into VADs' impact on renal function is warranted.
Related Concept Videos
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...